Business Context and Reporting Period
This Form 8-K Current Report from BiomX Inc. (PHGE) covers the special meeting of stockholders held on April 10, 2026. The filing details the voting results for proposals submitted to shareholders, with a record date of March 23, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
At the special meeting, 3,409,604 votes were present out of 6,543,516 shares outstanding. All proposals were approved by the stockholders:
- Proposal 1: Approval of the BiomX Inc. 2026 Equity Incentive Plan. This plan authorizes the issuance of up to 1,390,000 shares of Common Stock, with an annual automatic increase of 4% of the total shares outstanding on December 31 of the preceding year for ten years.
- Proposal 2: Approval of a proposal to adjourn the meeting if necessary to solicit further proxies. No adjournment was required.
Voting breakdown for both proposals was identical: 3,395,917 votes For, 5,009 votes Against, and 8,678 votes Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the final results of the shareholder vote.
Key Facts for Investor Verification
- Verification of the 1,390,000 share authorization under the new 2026 Equity Incentive Plan.
- Confirmation of the 4% annual automatic increase mechanism for the equity plan over the next decade.
- Review of the definitive proxy statement filed on March 25, 2026, for detailed terms of the approved proposals.
- Assessment of potential dilution impact from the newly authorized shares.